In particular, CAIX appears to be highly expressed in breast cancer and has relatively low expression in normal tissues [37–40] and expression is located on the extracellular surface of cell membranes, allowing for efficient targeting by monoclonal antibodies or small molecule inhibitors. This evidence concerns the gene CA9 and breast carcinoma.